Isolated “on-pump” tricuspid valve repair through right-sided anterolateral thoracotomy by modified femoral-monocaval cannulation in patients with repeated heart intervention – a safe and effective surgical alternative

Authors

DOI:

https://doi.org/10.14739/mmt.2024.3.303524

Keywords:

single-center study, tricuspid insufficiency, reoperation, anterolateral thoracotomy, isolated annuloplication, aortic clamping, working heart strategy, cardioplegia, cannulation, control echocardiography

Abstract

Tricuspid valve dysfunction has always been considered less clinically important than left heart valve disease. Disruption of the tricuspid valve can lead to cardiac dysfunction, causing severe and irreversible complications in patients if not treated in time. Reoperations for tricuspid valve insufficiency are surgical procedures associated with particularly high peri- and postoperative risk. The optimal timing and strategies for surgical intervention in isolated tricuspid valve insufficiency remain controversial.

Aim. Improving the immediate and long-term outcomes of patients with a cardiac surgical profile by evaluating the efficacy and safety of isolated tricuspid valve repair on the working heart by right anterolateral thoracotomy with reintervention.

Materials and methods. A single-center retrospective observational study of the clinical data of 12 patients who underwent tricuspid valve monosurgery between January 2022 and March 2024 was conducted. We evaluated the results of surgery in patients with isolated tricuspid valve annuloplasty on a working heart through a right anterolateral thoracotomy. Planned surgery was performed in 100 % (n = 12) of patients. The average age of the patients was 68.8 ± 2.2 years. Patients were divided by sex as follows: women – 75 % (n = 9), men – 25 % (n = 3). We collected demographic data of the patients, results of echocardiography, surgical intervention, hospitalization, and EuroSCORE was calculated based on patient medical records.

Results. The degree of postoperative regurgitation of the tricuspid valve according to the results of control echocardiography significantly decreased compared to the degree of insufficiency before surgery. The level of in-hospital mortality in the first 30 days after surgery in the studied group was 8.33 % (n = 1) of cases. The average duration of parallel artificial circulation was 63.3 ± 8.6 min, surgical intervention lasted 271.67 ± 22.20 min, the average duration of postoperative inotropic support was 0.8 ± 0.2 days, transfusion of blood components was required in 8.33 % (n = 1) of cases, stay in the intensive care unit after surgery was 1.0 ± 0.9 days, the total duration of hospitalization was 4.30 ± 1.72 days. Indicators of renal failure, EuroSCORE, episodes of cardiac arrhythmias, and other postoperative complications were significantly lower than with standard surgical techniques described in the current scientific literature.

Conclusions. Isolated tricuspid valve repair on the working heart through right anterolateral thoracotomy is a safe and effective surgical alternative in patients with reoperation. The use of right-sided anterolateral thoracotomy during repeated cardiac surgery allows preserving the integrity of the bone frame, avoiding technically difficult cardioplegia and aortic clamping, preventing damage to the main vessels and coronary arteries when mobilizing certain parts of the heart, and heart failure. Carrying out tricuspid valve plastic surgery on a working heart allows to achieve a good clinical result in patients with isolated tricuspid insufficiency at careful selection of the responders for the proposed technique with satisfactory terms of stay in the intensive care unit and in the hospital, the absence of ischemic and/or reperfusion damage to the heart, and a quick return to normal life activities. Indications for isolated surgery on the tricuspid valve should be based on reliable echocardiographic parameters of the right heart function.

Author Biographies

V. V. Osaulenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, Associate Professor of the Department of Surgery 1, Educational and Scientific Institute of Postgraduate Education

V. O. Hubka, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, DSc, Professor, Head of the Department of Hospital Surgery

K. O. Chmul, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, Assistant of the Department of Hospital Surgery

R. I. Budahov, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

Senior Laboratory Assistant of the Department of Hospital Surgery

References

  1. Greco R, Muretti M, Djordjevic J, Jin XY, Hill E, Renna M, et al. Surgical Complexity and Outcome of Patients Undergoing Redo Aortic Valve Surgery. Open Heart. 2020;7(1):e001209. doi: https://doi.org/10.1136/openhrt-2019-001209
  2. Lu S, Song K, Yao W, Xia L, Dong L, Sun Y, et al. Simplified, minimally invasive, beating-heart technique for redo isolated tricuspid valve surgery. J Cardiothorac Surg. 2020;15(1):146. doi: https://doi.org/10.1186/s13019-020-01192-1
  3. Vakilian F, Tavallaie A, Alimi H, Poorzand H, Salehi M. Right Atrial Strain in the Assessment of Right Heart Mechanics in Patients with Heart Failure with Reduced Ejection Fraction. J Cardiovasc Imaging. 2021;29(2):135-43. doi: https://doi.org/10.4250/jcvi.2020.0092
  4. Tafti S, Alaeddini F, Shirzad M, Bagheri J, Omran AS, Mahalleh M, et al. Isolated tricuspid valve surgery; long-term outcomes based on Tehran Heart Center data bank report. J Cardiothorac Surg. 2021;16(1):19. doi: https://doi.org/10.1186/s13019-021-01394-1
  5. Dreyfus J, Flagiello M, Bazire B, Eggenspieler F, Viau F, Riant E, et al. Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J. 2020;41(45):4304-17. doi: https://doi.org/10.1093/eurheartj/ehaa643
  6. Nenna A, Singh S, Nappi P, Chello M, Nappi F. Transcatheter tricuspid valve interventions: current approaches and future perspectives. Surg Technol Int. 2019;34:321‐9.
  7. Delgado V, Ajmone Marsan N, Bax JJ. The difficult decision of when and in whom to perform isolated tricuspid valve surgery. Eur Heart J. 2020;41(45):4318-20. doi: https://doi.org/10.1093/eurheartj/ehaa740
  8. Kandakure PR, Batra M, Garre S, Banovath SN, Shaikh F, Pani K. Direct Cannulation in Minimally Invasive Cardiac Surgery With Limited Resources. Ann Thorac Surg. 2020;109(2):512-6. doi: https://doi.org/10.1016/j.athoracsur.2019.05.075
  9. Abdelbar A, Kenawy A, Zacharias J. Minimally invasive tricuspid valve surgery. J Thorac Dis. 2021;13(3):1982-92. doi: https://doi.org/10.21037/jtd-20-1331
  10. Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, et al. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints. Eur Heart J. 2023;44(43):4508-32. doi: https://doi.org/10.1093/eurheartj/ehad653
  11. Zubarevich A, Szczechowicz M, Brcic A, Osswald A, Tsagakis K, Wendt D, et al. Tricuspid valve repair in isolated tricuspid pathology: a 12-year single center experience. J Cardiothorac Surg. 2020;15(1):330. doi: https://doi.org/10.1186/s13019-020-01369-8
  12. Bigdelu L, Azari A, Mashayekhi Z, Dadgarmoghaddam M, Baradaran Rahimi V. A comparative study on the results of beating and arrested heart isolated tricuspid valve surgery: A cross-sectional study. Health Sci Rep. 2022;5(4):e702. doi: https://doi.org/10.1002/hsr2.702
  13. Russo M, Di Mauro M, Saitto G, Lio A, Berretta P, Taramasso M, et al. Beating Versus Arrested Heart Isolated Tricuspid Valve Surgery: Long-term Outcomes. Ann Thorac Surg. 2022;113(2):585-92. doi: https://doi.org/10.1016/j.athoracsur.2021.03.070
  14. Flagiello M, Grinberg D, Connock M, Armoiry X, Buzzi R, Thibault H, et al. Beating versus arrested heart isolated tricuspid valve surgery: An 11-year experience in the current era. J Card Surg. 2021;36(3):1020-7. doi: https://doi.org/10.1111/jocs.15390
  15. Liang W, Yue H, Li T, Qin X, Qian Y, Wu Z. The better substitute for tricuspid valve replacement in patients with severe isolated tricuspid regurgitation. Anatol J Cardiol. 2019;22(4):172-6. doi: https://doi.org/10.14744/AnatolJCardiol.2019.47381
  16. Wahba A, Milojevic M, Boer C, De Somer FM, Gudbjartsson T, van den Goor J, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Eur J Cardiothorac Surg. 2020;57(2):210-51. doi: https://doi.org/10.1093/ejcts/ezz267
  17. Cheng A, Ramsey AM. Minimally invasive cardiac surgery: state-of-the-art right heart surgical technique for tricuspid valve, atrial septal defect and myxoma. J Vis Surg 2019;5:63. doi: https://doi.org/10.21037/jovs.2019.07.01
  18. Lee H, Kim J, Jung JH, Yoo JS. Midterm outcomes of isolated tricuspid valve surgery with a mini-thoracotomy and beating heart strategy. J Thorac Dis. 2023;15(6):3126-32. doi: https://doi.org/10.21037/jtd-22-1868
  19. Buzzatti N, Iaci G, Taramasso M, Nisi T, Lapenna E, De Bonis M, et al. Long-term outcomes of tricuspid valve replacement after previous left-side heart surgery. Eur J Cardiothorac Surg. 2014;46(4):713-9;discussion 719. doi: https://doi.org/10.1093/ejcts/ezt638
  20. Pfannmüller B, Misfeld M, Borger MA, Etz CD, Funkat AK, Garbade J, et al. Isolated reoperative minimally invasive tricuspid valve operations. Ann Thorac Surg. 2012;94(6):2005-10. doi: https://doi.org/10.1016/j.athoracsur.2012.06.064
  21. Hanedan MO, Çiçekçioğlu F, Aksöyek A, Diken Aİ, Ünal EU, Parlar Aİ, et al. Tricuspid Valve Replacement Through Right Thoracotomy has Better Outcomes in Redo Cases. Heart Lung Circ. 2017;26(1):88-93. doi: https://doi.org/10.1016/j.hlc.2016.05.118

Downloads

Additional Files

Published

2024-09-30

How to Cite

Osaulenko, V. V., Hubka, V. O., Chmul, K. O., & Budahov, R. I. (2024). Isolated “on-pump” tricuspid valve repair through right-sided anterolateral thoracotomy by modified femoral-monocaval cannulation in patients with repeated heart intervention – a safe and effective surgical alternative. Modern Medical Technology, 16(3), 235–242. https://doi.org/10.14739/mmt.2024.3.303524

Issue

Vol. 16 No. 3 (2024)

Section

Clinical cases

License

The work is provided under the terms of the Public Offer and of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows an unlimited number of persons to reproduce and share the Licensed Material in all media and formats. Any use of the Licensed Material shall contain an identification of its Creator(s) and must be for non-commercial purposes only.